中国卫生产业
中國衛生產業
중국위생산업
CHINA HEALTH INDUSTRY
2014年
28期
26-28
,共3页
胃癌%Q-PCR%ERCC1%预后
胃癌%Q-PCR%ERCC1%預後
위암%Q-PCR%ERCC1%예후
Gastric%Q-PCR%ERCC1%Prognosis
目的:探讨ERCC1基因在胃癌中的表达及临床意义。方法应用实时荧光定量PCR检测44例胃癌组织中ERCC1基因的表达,并分析ERCC1基因表达与患者生存的关系。结果ERCC1在胃癌组织中的表达与年龄、组织学分级、淋巴结转移、临床分期等因素无关,而与性别有关。 ERCC1高表达病例3年生存率33.3%(8/24),ERCC1低表达病例3年生存率60.0%(12/20),ERCC1低表达患者3年生存率更高,但是两者差异无统计学意义(P=0.077)。结论 ERCC1与胃癌分化程度、有无淋巴结转移等无关,提示ERCC1与肿瘤的不良生物学行为无关。 ERCC1基因在胃癌中不能作为独立的预后指标。
目的:探討ERCC1基因在胃癌中的錶達及臨床意義。方法應用實時熒光定量PCR檢測44例胃癌組織中ERCC1基因的錶達,併分析ERCC1基因錶達與患者生存的關繫。結果ERCC1在胃癌組織中的錶達與年齡、組織學分級、淋巴結轉移、臨床分期等因素無關,而與性彆有關。 ERCC1高錶達病例3年生存率33.3%(8/24),ERCC1低錶達病例3年生存率60.0%(12/20),ERCC1低錶達患者3年生存率更高,但是兩者差異無統計學意義(P=0.077)。結論 ERCC1與胃癌分化程度、有無淋巴結轉移等無關,提示ERCC1與腫瘤的不良生物學行為無關。 ERCC1基因在胃癌中不能作為獨立的預後指標。
목적:탐토ERCC1기인재위암중적표체급림상의의。방법응용실시형광정량PCR검측44례위암조직중ERCC1기인적표체,병분석ERCC1기인표체여환자생존적관계。결과ERCC1재위암조직중적표체여년령、조직학분급、림파결전이、림상분기등인소무관,이여성별유관。 ERCC1고표체병례3년생존솔33.3%(8/24),ERCC1저표체병례3년생존솔60.0%(12/20),ERCC1저표체환자3년생존솔경고,단시량자차이무통계학의의(P=0.077)。결론 ERCC1여위암분화정도、유무림파결전이등무관,제시ERCC1여종류적불량생물학행위무관。 ERCC1기인재위암중불능작위독립적예후지표。
Objective To evaluate the significance of ERCC1 in gastric cancer and the relationship between these markers and clinicopathologic parameter as well as clinical outcome. Methods Real-time PCR was used in detecting the expression of ERCC1 in 44 cases of microdissected formalin-fixed paraffin-embedded gastric cancer. Results The expression of ERCC1 in gastric cancer was correlated with gender (P=0.006) rather than age, histological grade, lymph node metastasis and TNM stage (P>0.05). The patients with low expression of ERCC1 showed higher survival rate, but it did not reach statistically significant difference (P>0.05); Conclusion The expression of ERCC1 in gastric cancer was not correlated with histological grade and lymph node metastasis, which indicate that the expression of ERCC1 has no relationship with tumor biological behavior. ERCC1 gene can not be considered as an independent prognosis factor.